| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2006 | CN1273478C Novel nucleosides and oligonucleotide analogues |
| 09/06/2006 | CN1273476C Oligonucleotide analoguse |
| 09/06/2006 | CN1273475C 6-0-substituted ketolides having antibacterial activity |
| 09/06/2006 | CN1273470C Polycyclic xanthones as antibiotics |
| 09/06/2006 | CN1273469C Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 09/06/2006 | CN1273467C Beta-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273465C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 09/06/2006 | CN1273464C Optically pure R-(+)- Omeprazole prepn process |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273460C Benzofuran and benzothiophene derivatives |
| 09/06/2006 | CN1273456C Thiazole or oxazole derivatives |
| 09/06/2006 | CN1273454C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/06/2006 | CN1273452C 7-(4,4-dimethyl-3-aminomethylpentazane-1-yl) substituted quinoline carboxylic acid derivative and its preparation |
| 09/06/2006 | CN1273451C Piperidine MCH antagonists and their use in treatment of obesity |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273449C Crystalline forms of atorvastatin |
| 09/06/2006 | CN1273446C Bearing-resisting compound and preparing method |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273435C Process for producing ibuprofen microcrystal |
| 09/06/2006 | CN1273194C Oral solid solution formulation of a poorly water-soluble active substance |
| 09/06/2006 | CN1273146C Composition for treating tumor |
| 09/06/2006 | CN1273144C Excretion accelerator for accumulative chlorine compound |
| 09/06/2006 | CN1273143C Transdermal electrotransport device and method for manufacturing the same |
| 09/06/2006 | CN1273142C Ethanolate of azithromycin, its preparation method and pharmaceutical compositions thereof |
| 09/06/2006 | CN1273141C Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate and preparation method thereof |
| 09/06/2006 | CN1273140C Cathartic composition |
| 09/06/2006 | CN1273139C Soft capsule of levogyrate ofloxacin and preparation method |
| 09/06/2006 | CN1273138C Sustained-release preparations of quinolone antibiotics and preparation method thereof |
| 09/06/2006 | CN1273137C Compound preparation containing Brufen arginine codeine |
| 09/06/2006 | CN1273136C Compound chlorhexidine acetate cream |
| 09/06/2006 | CN1273135C Pharmaceutical composition of N-methyl-D-aspartate receptor agonist |
| 09/06/2006 | CN1273134C Soft capsule of fibrauretine and preparation method thereof |
| 09/06/2006 | CN1273133C Berberine hydrochloride granule for masking flavor and its preparation |
| 09/06/2006 | CN1273132C Aromatase inhibitor |
| 09/06/2006 | CN1273131C Application of maltol in preparation of medicine for preventing and treating neuroretrogressive diseases |
| 09/06/2006 | CN1273130C Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 09/06/2006 | CN1273129C Therapeutic compositions (II) |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/06/2006 | CN1273127C Perfume compositions |
| 09/06/2006 | CN1273126C Compositions for regulating desire for smoking |
| 09/06/2006 | CN1273125C Application of BAPTA derivative in the preparing process of clinical medicine |
| 09/06/2006 | CN1273124C Medicinal composition containing calcium and iron elements |
| 09/06/2006 | CN1273123C Application of (3R,4R)-delta 8-tetrahydrocannabinol)-11-acid in preparation of medicine for reducing cell proliferation |
| 09/06/2006 | CN1273122C Colchicine osmosis pump tablet |
| 09/06/2006 | CN1273121C Compounds for blocking androgen receptors |
| 09/06/2006 | CN1273120C Parasiticidal composition and methods of use |
| 09/06/2006 | CN1273119C Anti-atherosclerosis composition containing carotenoilds and method for inhibiting LDL oxidation |
| 09/06/2006 | CN1273115C Quick-acting and heart-resurrecting oral disintegrating tablet and its preparation process |
| 09/06/2006 | CN1273113C Powder processing with pressurized gaseous fluids |
| 09/06/2006 | CN1273112C Fibrate-statin combinations with food-reducing and -fasting function |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/06/2006 | CN1273107C Preparation process of a Chinese medicinal drop pills for preventing or treating coronary disease |
| 09/06/2006 | CN1273024C Medicine containing bamboo vinegar, chitosan and silver ion, and preparation method and application thereof |
| 09/06/2006 | CN1273019C Parasiticide and parasitic method for globefish |
| 09/05/2006 | USRE39267 Thienopyrimidine-based inhibitors of the SRC family |
| 09/05/2006 | USRE39266 5-[4-[2-[2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl]ethoxy]phenyl methyl]thiazolidine-2,4-dione; intermediate compound for antidiabetic drug |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | USRE39264 Pharmaceutical combination |
| 09/05/2006 | US7102026 Reacting ethyl pyruvate with methyl methacrylate |
| 09/05/2006 | US7102020 Total synthesis of daurichromenic acid |
| 09/05/2006 | US7102019 Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102011 Visualizing cellular organelles and cytoskeletons; obtain tissue sample, fix tissue, incubate with crystalizing agents, visualizing cellular organelles, visualize crystals formed in organelles detect numbers and shape of oganelle |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102008 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7102003 4-(1-(3-Fluorobenzyl)-1H-indazol-5-ylamino)pyrrolo[1,2-f][1,2,4]triazin-5-ol; inhibiting tyrosine kinase activity of growth factor receptors; antiproliferative agents, anticancer agents |
| 09/05/2006 | US7102002 Pyrrolotriazine kinase inhibitors |
| 09/05/2006 | US7102001 Process for preparing pyrrolotriazine |
| 09/05/2006 | US7102000 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| 09/05/2006 | US7101995 Drug delivery to inhibit abnormal gene expression in mammalian cells; small interfering RNAs (siRNA) |
| 09/05/2006 | US7101994 Process for preparing substituted benzimidazole compounds |
| 09/05/2006 | US7101991 antisense hsp27 oligonucleotides or RNAi nucleotide inhibitors |
| 09/05/2006 | US7101990 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101960 Process for removing bile salts from a patient and alkylated compositions therefor |
| 09/05/2006 | US7101917 Mitochrondrial permeability transition pore affinity labels and modulators |
| 09/05/2006 | US7101916 Exo-S-mecamylamine formulation and use in treatment |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 09/05/2006 | US7101914 Isomer enriched conjugated linoleic acid compositions |
| 09/05/2006 | US7101913 Oleic acid ester derivative; avocado extract in n-hexane solvent |
| 09/05/2006 | US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101909 Compound of a ligand of 2-methoxy methylester-6-fluoronaphthalene, an aryl ligand and a linker; each ligand domain capable of binding to a Ca++ channel |
| 09/05/2006 | US7101908 Nontoxic treatment for infections from cytomegalovirus |
| 09/05/2006 | US7101907 Topical administration of statins for treatment of bone disorders |
| 09/05/2006 | US7101905 Pharmaceutically active compounds and methods of use |
| 09/05/2006 | US7101904 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/05/2006 | US7101903 9-(4-Methylbenzyl)-6-[4-(trifluoromethoxy)phenyl]-1,9-dihydropyrano[3,4-b]indole-3,4-dione; treating fibrinolytic disorders, vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 09/05/2006 | US7101902 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
| 09/05/2006 | US7101901 Treating Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 09/05/2006 | US7101900 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101898 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2006 | US7101897 Farnesyl transferase inhibitors |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |
| 09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 09/05/2006 | US7101894 Administering quinoline derivative for therapy of Cytomegalovirus infections in human pathogen |